Does the media prefer HCAT or AMWL?

In the previous week, American Well had 1 more articles in the media than Health Catalyst. MarketBeat recorded 2 mentions for American Well and 1 mentions for Health Catalyst. American Well's average media sentiment score of 1.00 beat Health Catalyst's score of 0.89 indicating that American Well is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health Catalyst 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive American Well 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer OPRX or HCAT?

In the previous week, OptimizeRx had 1 more articles in the media than Health Catalyst. MarketBeat recorded 2 mentions for OptimizeRx and 1 mentions for Health Catalyst. Health Catalyst's average media sentiment score of 0.89 beat OptimizeRx's score of 0.66 indicating that Health Catalyst is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OptimizeRx 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Health Catalyst 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor DH or HCAT?

In the previous week, Definitive Healthcare had 5 more articles in the media than Health Catalyst. MarketBeat recorded 6 mentions for Definitive Healthcare and 1 mentions for Health Catalyst. Health Catalyst's average media sentiment score of 0.89 beat Definitive Healthcare's score of 0.55 indicating that Health Catalyst is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Definitive Healthcare 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Health Catalyst 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer DRIO or HCAT?

In the previous week, DarioHealth and DarioHealth both had 1 articles in the media. DarioHealth's average media sentiment score of 1.67 beat Health Catalyst's score of 0.89 indicating that DarioHealth is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DarioHealth 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Health Catalyst 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Health Catalyst (HCAT) Competitors

$1.70 +0.01 (+0.30%)

As of 01:21 PM Eastern

Compare

HCAT vs. AMWL, OPRX, CCLD, DH, and DRIO

Should you buy Health Catalyst stock or one of its competitors? Health Catalyst's main competitors and comparable companies include American Well (AMWL), OptimizeRx (OPRX), CareCloud (CCLD), Definitive Healthcare (DH), and DarioHealth (DRIO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Health Catalyst compare to American Well?

Health Catalyst (NASDAQ:HCAT) and American Well (NYSE:AMWL) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk.

American Well has a net margin of -35.75% compared to Health Catalyst's net margin of -90.61%. Health Catalyst's return on equity of -1.83% beat American Well's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health Catalyst	-90.61%	-1.83%	-0.80%
American Well	-35.75%	-30.12%	-22.30%

In the previous week, American Well had 1 more articles in the media than Health Catalyst. MarketBeat recorded 2 mentions for American Well and 1 mentions for Health Catalyst. American Well's average media sentiment score of 1.00 beat Health Catalyst's score of 0.89 indicating that American Well is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health Catalyst	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
American Well	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

American Well has lower revenue, but higher earnings than Health Catalyst. American Well is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health Catalyst	$311.14M	0.41	-$177.97M	-$3.68	N/A
American Well	$249.32M	0.87	-$95.70M	-$4.77	N/A

Health Catalyst has a beta of 1.53, meaning that its share price is 53% more volatile than the broader market. Comparatively, American Well has a beta of 1.71, meaning that its share price is 71% more volatile than the broader market.

85.0% of Health Catalyst shares are owned by institutional investors. Comparatively, 56.1% of American Well shares are owned by institutional investors. 19.4% of Health Catalyst shares are owned by insiders. Comparatively, 12.8% of American Well shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Health Catalyst presently has a consensus price target of $2.45, suggesting a potential upside of 43.70%. American Well has a consensus price target of $9.50, suggesting a potential downside of 27.84%. Given Health Catalyst's stronger consensus rating and higher possible upside, analysts plainly believe Health Catalyst is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health Catalyst	1 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.17
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Health Catalyst beats American Well on 10 of the 16 factors compared between the two stocks.

How does Health Catalyst compare to OptimizeRx?

OptimizeRx (NASDAQ:OPRX) and Health Catalyst (NASDAQ:HCAT) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, profitability, valuation, risk and institutional ownership.

OptimizeRx currently has a consensus target price of $11.43, indicating a potential upside of 42.77%. Health Catalyst has a consensus target price of $2.45, indicating a potential upside of 43.70%. Given Health Catalyst's higher probable upside, analysts clearly believe Health Catalyst is more favorable than OptimizeRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OptimizeRx	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
Health Catalyst	1 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.17

OptimizeRx has a beta of 1.09, meaning that its stock price is 9% more volatile than the broader market. Comparatively, Health Catalyst has a beta of 1.53, meaning that its stock price is 53% more volatile than the broader market.

76.5% of OptimizeRx shares are owned by institutional investors. Comparatively, 85.0% of Health Catalyst shares are owned by institutional investors. 7.5% of OptimizeRx shares are owned by company insiders. Comparatively, 19.4% of Health Catalyst shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

OptimizeRx has higher earnings, but lower revenue than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptimizeRx	$109.43M	1.38	$5.13M	$0.23	34.80
Health Catalyst	$311.14M	0.41	-$177.97M	-$3.68	N/A

OptimizeRx has a net margin of 4.66% compared to Health Catalyst's net margin of -90.61%. OptimizeRx's return on equity of 9.44% beat Health Catalyst's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OptimizeRx	4.66%	9.44%	7.11%
Health Catalyst	-90.61%	-1.83%	-0.80%

In the previous week, OptimizeRx had 1 more articles in the media than Health Catalyst. MarketBeat recorded 2 mentions for OptimizeRx and 1 mentions for Health Catalyst. Health Catalyst's average media sentiment score of 0.89 beat OptimizeRx's score of 0.66 indicating that Health Catalyst is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OptimizeRx	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Health Catalyst	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

OptimizeRx beats Health Catalyst on 10 of the 16 factors compared between the two stocks.

How does Health Catalyst compare to CareCloud?

Health Catalyst (NASDAQ:HCAT) and CareCloud (NASDAQ:CCLD) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, analyst recommendations, profitability and dividends.

Health Catalyst has a beta of 1.53, indicating that its share price is 53% more volatile than the broader market. Comparatively, CareCloud has a beta of 1.5, indicating that its share price is 50% more volatile than the broader market.

In the previous week, Health Catalyst had 1 more articles in the media than CareCloud. MarketBeat recorded 1 mentions for Health Catalyst and 0 mentions for CareCloud. Health Catalyst's average media sentiment score of 0.89 beat CareCloud's score of 0.00 indicating that Health Catalyst is being referred to more favorably in the media.

Company	Overall Sentiment
Health Catalyst	Positive
CareCloud	Neutral

CareCloud has a net margin of 6.21% compared to Health Catalyst's net margin of -90.61%. CareCloud's return on equity of 27.07% beat Health Catalyst's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health Catalyst	-90.61%	-1.83%	-0.80%
CareCloud	6.21%	27.07%	14.56%

CareCloud has lower revenue, but higher earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health Catalyst	$311.14M	0.41	-$177.97M	-$3.68	N/A
CareCloud	$128.64M	0.74	$10.80M	$0.07	32.07

Health Catalyst presently has a consensus target price of $2.45, suggesting a potential upside of 43.70%. CareCloud has a consensus target price of $3.25, suggesting a potential upside of 44.77%. Given CareCloud's stronger consensus rating and higher probable upside, analysts clearly believe CareCloud is more favorable than Health Catalyst.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health Catalyst	1 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.17
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

85.0% of Health Catalyst shares are held by institutional investors. Comparatively, 10.2% of CareCloud shares are held by institutional investors. 19.4% of Health Catalyst shares are held by insiders. Comparatively, 14.8% of CareCloud shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

CareCloud beats Health Catalyst on 9 of the 16 factors compared between the two stocks.

How does Health Catalyst compare to Definitive Healthcare?

Definitive Healthcare (NASDAQ:DH) and Health Catalyst (NASDAQ:HCAT) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, institutional ownership, media sentiment, dividends, risk, analyst recommendations, earnings and valuation.

Definitive Healthcare has a net margin of -72.28% compared to Health Catalyst's net margin of -90.61%. Definitive Healthcare's return on equity of 3.55% beat Health Catalyst's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Definitive Healthcare	-72.28%	3.55%	1.63%
Health Catalyst	-90.61%	-1.83%	-0.80%

Definitive Healthcare has a beta of 1.4, indicating that its stock price is 40% more volatile than the broader market. Comparatively, Health Catalyst has a beta of 1.53, indicating that its stock price is 53% more volatile than the broader market.

Definitive Healthcare has higher earnings, but lower revenue than Health Catalyst. Definitive Healthcare is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Definitive Healthcare	$232.70M	0.47	-$138.93M	-$1.60	N/A
Health Catalyst	$311.14M	0.41	-$177.97M	-$3.68	N/A

Definitive Healthcare currently has a consensus price target of $1.47, indicating a potential upside of 43.55%. Health Catalyst has a consensus price target of $2.45, indicating a potential upside of 43.70%. Given Health Catalyst's stronger consensus rating and higher possible upside, analysts clearly believe Health Catalyst is more favorable than Definitive Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Definitive Healthcare	3 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	1.89
Health Catalyst	1 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.17

98.7% of Definitive Healthcare shares are held by institutional investors. Comparatively, 85.0% of Health Catalyst shares are held by institutional investors. 17.1% of Definitive Healthcare shares are held by insiders. Comparatively, 19.4% of Health Catalyst shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Definitive Healthcare had 5 more articles in the media than Health Catalyst. MarketBeat recorded 6 mentions for Definitive Healthcare and 1 mentions for Health Catalyst. Health Catalyst's average media sentiment score of 0.89 beat Definitive Healthcare's score of 0.55 indicating that Health Catalyst is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Definitive Healthcare	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Health Catalyst	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Definitive Healthcare beats Health Catalyst on 9 of the 17 factors compared between the two stocks.

How does Health Catalyst compare to DarioHealth?

DarioHealth (NASDAQ:DRIO) and Health Catalyst (NASDAQ:HCAT) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk, analyst recommendations and media sentiment.

In the previous week, DarioHealth and DarioHealth both had 1 articles in the media. DarioHealth's average media sentiment score of 1.67 beat Health Catalyst's score of 0.89 indicating that DarioHealth is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DarioHealth	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Health Catalyst	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

DarioHealth has a beta of 1.12, meaning that its stock price is 12% more volatile than the broader market. Comparatively, Health Catalyst has a beta of 1.53, meaning that its stock price is 53% more volatile than the broader market.

Health Catalyst has a net margin of -90.61% compared to DarioHealth's net margin of -169.87%. Health Catalyst's return on equity of -1.83% beat DarioHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DarioHealth	-169.87%	-54.81%	-33.36%
Health Catalyst	-90.61%	-1.83%	-0.80%

33.4% of DarioHealth shares are owned by institutional investors. Comparatively, 85.0% of Health Catalyst shares are owned by institutional investors. 3.5% of DarioHealth shares are owned by insiders. Comparatively, 19.4% of Health Catalyst shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

DarioHealth presently has a consensus price target of $10.00, suggesting a potential upside of 40.37%. Health Catalyst has a consensus price target of $2.45, suggesting a potential upside of 43.70%. Given Health Catalyst's higher probable upside, analysts plainly believe Health Catalyst is more favorable than DarioHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Health Catalyst	1 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.17

DarioHealth has higher earnings, but lower revenue than Health Catalyst. DarioHealth is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DarioHealth	$21.00M	3.32	-$41.71M	-$6.13	N/A
Health Catalyst	$311.14M	0.41	-$177.97M	-$3.68	N/A

Summary

Health Catalyst beats DarioHealth on 11 of the 15 factors compared between the two stocks.

Get Health Catalyst News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HCAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HCAT vs. The Competition

Export

Metric	Health Catalyst	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$128.32M	$1.76B	$7.26B	$12.90B
Dividend Yield	N/A	4.70%	2.53%	8.56%
P/E Ratio	-0.46	21.40	273.76	25.42
Price / Sales	0.41	83.68	679.75	124.45
Price / Cash	0.80	31.85	76.98	52.08
Price / Book	1.27	7.35	12.91	6.15
Net Income	-$177.97M	-$26.60M	$3.48B	$349.24M
7 Day Performance	7.23%	0.24%	-0.18%	-1.39%
1 Month Performance	-22.85%	12.56%	6.63%	2.55%
1 Year Performance	-47.38%	-14.88%	25.25%	15.80%

Health Catalyst Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HCAT Health Catalyst	3.0486 of 5 stars	$1.70 +0.3%	$2.45 +44.5%	-50.3%	$127.57M	$311.14M	N/A	1,200
AMWL American Well	2.3563 of 5 stars	$11.45 -3.9%	$9.50 -17.0%	+90.0%	$189.50M	$249.32M	N/A	1,040	Positive News
OPRX OptimizeRx	4.3357 of 5 stars	$7.88 +2.9%	$11.43 +45.1%	-53.1%	$148.82M	$109.43M	34.34	100
CCLD CareCloud	4.221 of 5 stars	$2.42 -3.4%	$3.25 +34.6%	-39.1%	$102.62M	$128.64M	34.50	3,650
DH Definitive Healthcare	2.5206 of 5 stars	$0.72 -0.1%	$1.47 +104.4%	-72.7%	$76.86M	$232.70M	N/A	970	News Coverage Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HCAT) was last updated on 9/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Health Catalyst (HCAT) Competitors

HCAT vs. AMWL, OPRX, CCLD, DH, and DRIO

How does Health Catalyst compare to American Well?

Summary

How does Health Catalyst compare to OptimizeRx?

Summary

How does Health Catalyst compare to CareCloud?

Summary

How does Health Catalyst compare to Definitive Healthcare?

Summary

How does Health Catalyst compare to DarioHealth?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HCAT vs. The Competition

Health Catalyst Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Health Catalyst (HCAT) Competitors

HCAT vs. AMWL, OPRX, CCLD, DH, and DRIO

How does Health Catalyst compare to American Well?

Is HCAT or AMWL more profitable?

Does the media prefer HCAT or AMWL?

Which has preferable earnings and valuation, HCAT or AMWL?

Which has more volatility and risk, HCAT or AMWL?

Do insiders and institutionals hold more shares of HCAT or AMWL?

Do analysts prefer HCAT or AMWL?

Summary

How does Health Catalyst compare to OptimizeRx?

Do analysts prefer OPRX or HCAT?

Which has more risk and volatility, OPRX or HCAT?

Do insiders and institutionals have more ownership in OPRX or HCAT?

Which has better valuation and earnings, OPRX or HCAT?

Is OPRX or HCAT more profitable?

Does the media prefer OPRX or HCAT?

Summary

How does Health Catalyst compare to CareCloud?

Which has more risk and volatility, HCAT or CCLD?

Does the media refer more to HCAT or CCLD?

Is HCAT or CCLD more profitable?

Which has stronger valuation and earnings, HCAT or CCLD?

Do analysts rate HCAT or CCLD?

Do insiders and institutionals believe in HCAT or CCLD?

Summary

How does Health Catalyst compare to Definitive Healthcare?

Is DH or HCAT more profitable?

Which has more volatility & risk, DH or HCAT?

Which has stronger earnings and valuation, DH or HCAT?

Do analysts rate DH or HCAT?

Do institutionals and insiders believe in DH or HCAT?

Does the media favor DH or HCAT?

Summary

How does Health Catalyst compare to DarioHealth?

Does the media prefer DRIO or HCAT?

Which has more risk & volatility, DRIO or HCAT?

Is DRIO or HCAT more profitable?

Do insiders & institutionals have more ownership in DRIO or HCAT?

Do analysts rate DRIO or HCAT?

Which has stronger valuation & earnings, DRIO or HCAT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HCAT vs. The Competition

Health Catalyst Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools